QIAGEN powered by

Webinars and events

Loading Events

« All Events

  • This event has passed.

Lowering NGS analysis cost at lightspeed

March 22, 2023 @ 12:00 pm - 1:00 pm

Advances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications, such that they are considered the standard of care within multiple healthcare organizations. Arguably, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity, specificity, cost and speed are critical for secondary analysis, while accurate, comprehensive and up-to-date content is required for reliable interpretation. These aspects are crucial, especially where rapid turnaround times are critical for improved health outcomes. There is no better example than the implementation of WES and WGS in the neonatal and pediatric intensive care units (NICU/PICU).

Join this webinar to learn about QIAGEN CLC LightSpeed, a secondary analysis software that dramatically reduces the cost and time it takes to analyze WES and WGS data and generate actionable insights.

Key learning objectives

  • Learn how to process FASTQ files to obtain quality variant calls in minutes
  • Discover how LightSpeed can be used on existing laptops, desktops, servers, HPC or in the cloud
  • Learn how LightSpeed will reduce your cost without sacrificing quality
  • Explore how LightSpeed enables the fastest WES and WGS workflow from FASTQ to report

Who should attend?

Bioinformaticians, Geneticists, Lab managers, NGS technicians, researchers, and biologists

Details

Date: March 22, 2023
Time:
 12:00 pm - 1:00 pm
Register for event
Event Categories:
,
Event Tags:
,

Venue

Virtual – Americas – EST
NY United States

Organizer

Organizer Information

Register for event

On-demand Webinars


  • On-demand webinar: Get insights into the bioinformatics analysis of Nanopore sequencing data for SARS-CoV-2

    The study of the COVID-19 pandemic often involves sequencing the SARS-CoV-2 virus using Illumina, Nanopore, IonTorrent and Sanger technologies alone or in combination. Depending on the sampling and library preparation method used, this can involve metatranscriptomic data of varying viral content. In this webinar tutorial, you will learn about: Best practices for ...

  • On-demand webinar: Discover hidden relationships in your toxicological studies with QIAGEN IPA

    QIAGEN Ingenuity Pathway Analysis (IPA) reveals the hidden upstream drivers and downstream outcomes in your toxicogenomics datasets. Put those results into context using Analysis Match with over 50,000 pre-analyzed datasets for human, mouse and rat. Explain the causes and effects in your studies so you can generate hypotheses to develop better drugs, biomarkers and mo...

  • On-demand web seminar: Enabling high-throughput genomic surveillance of emerging SARS-CoV-2 strains

    Join our webinar to discover a scalable workflow for SARS-CoV-2 whole genome sequencing to accelerate detection of variants such as B.1.1.7 and B.1.351. In this new webinar, we will describe how QIAGEN’s QIAseq SARS-CoV-2 integrated workflow combines QIAseq chemistries and CLC Genomics Analysis software to deliver a scalable, high-performance solution for sequencing...

  • On-demand webinar: Investigation of Somatic and Germline Variants by COSMIC, HGMD and QIAGEN Databases

    Identifying and studying actionable variants is of great interest to many investigators. In this webinar, COSMIC, HGMD and QIAGEN database will be introduced for annotation and investigation of both somatic and germline variants. Attendees will learn how to use QIAGEN Clinical Insight Interpret Translational (QCI-IT) to identify key actionable variants from whole geno...

  • On-demand Webinar: Whole exome sequencing (WES) helps understand exceptional survival in rare sarcoma patient

    In this webinar presented by Rockefeller University, Danbury Hospital and QDI, we present a unique case study of a treatment-naïve patient with aggressive metastatic uLMS who has experienced long-term survival. Using whole exome sequencing (WES), we analyzed 5 tumors to identify mechanisms of uLMS tumor growth and metastasis in this patient. Attendees of this webi...

  • On-demand Webinar: Accelerate R&D in new cancer drug development

    Learn about a new database that helps you accelerate cancer drug development. This is the ONE tool that all translational research programs need to accelerate cancer drug R&D. Free trials offered to all attendees.   Webinar Abstract The paradigm of predictive biomarkers of therapeutic responses to drug intervention has dramatically transformed cancer...

  • On-demand Webinar: Comprehensive Molecular Tumor Analysis with Alacris Theranostics

    Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the development, application, and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) test for cancer patients. Precision oncology approaches have made great strides harnessing individual tumor mutation profiles to guide targeted therapy choic...